Database Query Results : , , LymphAG

LymphAG, Lymphangiogenesis: Click to Expand ⟱
Source: HalifaxProj(impede)
Type:
Lymphangiogenesis is the process of forming new lymphatic vessels from pre-existing ones. Lymphangiogenesis is regulated by a range of growth factors and molecular signals, including vascular endothelial growth factor-C (VEGF-C), vascular endothelial growth factor-D (VEGF-D), and angiopoietins. Dysregulation of lymphangiogenesis has been implicated in various diseases, including cancer, lymphedema, and inflammatory disorders.
Lymphangiogenesis is often upregulated in cancer, promoting the growth and spread of tumors. The expression of lymphangiogenic factors, such as vascular endothelial growth factor-C (VEGF-C) and vascular endothelial growth factor-D (VEGF-D), is increased in many types of cancer, including breast, lung, colon, and melanoma.
Scientific Papers found: Click to Expand⟱

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 0

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: LymphAG, Lymphangiogenesis
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:176  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page